Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01270269 · ClinicalTrials.gov registry record · NA
ACT-ICU Study: Activity and Cognitive Therapy in the Intensive Care Unit
A NA study, sponsored by Vanderbilt University.
- Completed
- Registry status
- NA
- Development phase
- 87
- Enrollment target
NCT01270269: Completed NA study, sponsored by Vanderbilt University.
NCT01270269 is a NA study that has completed, run by Vanderbilt University. The registered enrollment target is 87 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01270269, a NA study, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- NA
- Development phase
- 87 participants
- Enrollment target
Study Summary
Intensive care unit (ICU) hospitalization saves lives but often does so at a high personal cost to ICU survivors who frequently experience significant cognitive impairment and an array of physical and functional disabilities that limit their recovery and quality of life. While the problems experienced by these patients are likely amenable to rehabilitation, few ICU survivors receive focused rehabilitation. Recently, early physical rehabilitation in ICU patients has shown to improve the chances a patient will regain their pre-hospital functional status. Early cognitive rehabilitation for these patients has not yet been explored. This pilot study will determine the feasibility of early cognitive rehabilitation in ICU patients. The investigators will perform cognitive and physical rehabilitation, beginning in the earliest phases of critical illness, to determine the effect of these therapies on cognitive and functional outcomes in ICU survivors. The investigators hypothesize that combined cognitive and physical rehabilitation, started in the ICU, will improve recovery of cognitive and physical function as well as improve quality of life of ICU survivors.
Primary Outcome
A psychometric measure of executive functioning.
Interventions
- BEHAVIORAL Behavioral: Physical and functional rehabilitation
- BEHAVIORAL Behavioral: Cognitive, physical, & functional rehabilitation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 87 participants |
| Start Date | 2011-02 |
| Est. Completion | 2014-06 |
| Phase | NA |
What the finished NCT01270269 record still lists
NCT01270269 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 87 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 2 interventions - of which Behavioral: Physical and functional rehabilitation is the first listed.
NCT01270269 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01270269 about?
NCT01270269 is a clinical study titled "ACT-ICU Study: Activity and Cognitive Therapy in the Intensive Care Unit". Intensive care unit (ICU) hospitalization saves lives but often does so at a high personal cost to ICU survivors who frequently experience significant cognitive impairment and an array of physical and functional disabilities that limit their recovery and quality of life. While the problems experienc...
What is the current status of trial NCT01270269?
This trial is currently completed. It is a NA study. The enrollment target is 87 participants. The study started on 2011-02. Estimated completion is 2014-06.
What interventions are being tested in trial NCT01270269?
The interventions under investigation include: Behavioral: Physical and functional rehabilitation (BEHAVIORAL), Behavioral: Cognitive, physical, & functional rehabilitation (BEHAVIORAL).
Who is sponsoring clinical trial NCT01270269?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01270269's enrollment target sits among peer trials
87 974th of 2000 higher than 1,025 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03292601 · 87 participants · NA
Brace Monitoring for Adolescent Idiopathic Scoliosis (AIS)
- NCT04291105 · 87 participants · Phase 2
Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients
- NCT04565795 · 87 participants · NA
Safety and Device Performance of the Uriprene® Degradable Temporary Ureteral Stent Following Uncomplicated Ureteroscopy
- NCT05607004 · 87 participants · Phase 2
(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia